LGNZZ Projected Dividend Yield
Tr Beta Contingent Value Rt/Ligand Pharmaceuticals Inc ( OTCBB : LGNZZ )Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. Co.'s collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. 18 YEAR PERFORMANCE RESULTS |
LGNZZ Dividend History Detail LGNZZ Dividend News LGNZZ Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |